Expert Interview
Discussing Reata Pharma's Omaveloxolone in treating Friedreich's Ataxia
Ticker(s): RETAInstitution: University of Louisville
- Professor of Neurology, Medical Geneticist, Endowed Chair of Parkinson’s Disease Research, & Director, Movement Disorders Program at University of Louisville.
- Manages 90 patients with Huntington's disease and 35 patients with Friedreich’s Ataxia.
- Research interests are focused on understanding the underlying genetic basis of hereditary spastic paraplegia and essential tremor; clinical interests include surgical therapies for Parkinson's disease, essential tremor and dystonia, and botulinum toxin procedures for dystonia and spasticity.
Please describe your practice as a clinician, how many patients with Friedreich's Ataxia do you see on a yearly basis? Can you describe the standard of care, and take us through the most promising upcoming treatments?
How does Omaveloxolone compare to other treatments for Friedreich's Ataxia in terms of effectiveness and safety?
How long does it typically take for patients to see improvement in their symptoms after starting treatment?
Added By: slingshot_insightsWhat is the long-term outlook for patients taking Omaveloxolone for Friedreich's Ataxia?
Added By: slingshot_insightsAre there any possible interactions between Omaveloxolone and other medications that the patient might be taking?
Is Omaveloxolone a suitable treatment option for all patients with Friedreich's Ataxia, or are there certain patient factors that may affect its effectiveness?
How does Omaveloxolone impact the daily life and functional abilities of patients with Friedreich's Ataxia?
Added By: slingshot_insightsWhat additional measures or treatments can be used alongside Omaveloxolone to manage the symptoms of Friedreich's Ataxia?
Can Omaveloxolone slow or halt the progression of Friedreich's Ataxia, or is it mainly used for symptom management?
Are there potential long-term risks associated with taking Omaveloxolone for the treatment of Friedreich's Ataxia?
Added By: slingshot_insightsCan Omaveloxolone be used in combination with other medications to enhance its effectiveness in treating Friedreich's Ataxia?
Added By: slingshot_insightsAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
